首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >Analysis of gene expression in osteogenic cultured marrow/hydroxyapatite construct implanted at ectopic sites: a comparison with the osteogenic ability of cancellous bone.
【24h】

Analysis of gene expression in osteogenic cultured marrow/hydroxyapatite construct implanted at ectopic sites: a comparison with the osteogenic ability of cancellous bone.

机译:在异位部位植入的成骨培养骨髓/羟基磷灰石构建体中的基因表达分析:与松质骨的成骨能力的比较。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We investigated the in vivo osteogenic ability of cultured marrow cells subcultured in porous hydroxyapatite. This osteogenic ability was compared with that of cancellous bone grafts. Fresh marrow cells were obtained from young adult rat femora and cultured in a standard medium for 10 days, then trypsinized and used to make constructs of porous hydroxyapatite (HA) and cultured marrow cells. An additional 2-week culture (subculture) was performed for the construct in standard medium with and without the addition of dexamethasone (Dex). The 2-week subcultured constructs then were implanted into subcutaneous sites of syngeneic rats. These implants and the rat cancellous bone were harvested and prepared for gene expression analysis of alkaline phosphatase (ALP) and osteocalcin (OC) as well as for histological analysis. ALP and OC mRNAs could be detected in Dex-treated subcultured constructs 1 week after implantation with an increase at 2 weeks, comparable to the observation in cancellous bone. Histological analysis showed active bone formation even 1 week postimplantation. In contrast, the subcultured constructs without the addition of Dex did not show bone formation, and only small levels of ALP and OC mRNAs were found. These results indicate that the bone tissue formed by grafting the Dex-treated construct of cultured marrow cells and hydroxyapatite possesses a high osteoblastic activity comparable to that of viable cancellous bone. Thus the prefabricated osteogenic subcultured marrow/HA construct may be applicable in bone reconstructive surgery.
机译:我们研究了在多孔羟基磷灰石中传代培养的骨髓细胞的体内成骨能力。将这种成骨能力与松质骨移植物进行了比较。从幼年成年大鼠股骨获得新鲜骨髓细胞,并在标准培养基中培养10天,然后进行胰蛋白酶消化,并用于制备多孔羟基磷灰石(HA)的构建体和培养的骨髓细胞。在有或没有添加地塞米松(Dex)的标准培养基中对该构建体进行另外的2周培养(传代培养)。然后将2周的亚培养构建体植入同系大鼠的皮下部位。收集这些植入物和大鼠松质骨,准备用于碱性磷酸酶(ALP)和骨钙素(OC)的基因表达分析以及组织学分析。植入后1周,在接受Dex处理的继代培养构建物中可检测到ALP和OC mRNA,而在2周时可检测到ALP和OC mRNA的增加,这与松质骨中的观察结果相当。组织学分析显示,即使在植入后1周,仍会形成活跃的骨形成。相反,未添加Dex的继代培养构建体未显示出骨形成,仅发现了少量的ALP和OC mRNA。这些结果表明,通过将经Dex处理的培养的骨髓细胞和羟基磷灰石移植而形成的骨组织具有与活松质骨相当的高成骨活性。因此,预制的成骨的继代培养的骨髓/ HA构建体可适用于骨重建手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号